Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cavalie Fanny Insider Profile
4 Followers
Cavalie Fanny, Chief Strategy/Bus Ops Officer at Foghorn Therapeutics, holds 86.99K shares in Foghorn Therapeutics (Ticker: FHTX). Most recently, Cavalie Fanny Sold $11,000 shares of Foghorn Therapeutics on Mar 12, 2024 for an estimated value of 72.05K.
Cavalie Fanny has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
Chief Strategy/Bus Ops Officer
Roles that Cavalie Fanny holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Cavalie Fanny
Cavalie Fanny's Trading History
List of latest transactions for each holding click on a transaction to see Cavalie Fanny's performance on stock
You May Also Like
Cavalie Fanny insider profile FAQ
What is the percentage of profitable transactions made by Cavalie Fanny?
The percentage of profitable transactions made by Cavalie Fanny is ―.
What is the average return per transaction made by Cavalie Fanny?
The average return per transaction made by Cavalie Fanny is ―.
What stocks does Cavalie Fanny hold?
Cavalie Fanny holds: FHTX stocks.
What was Cavalie Fanny’s latest transaction?
Cavalie Fanny latest transaction was an Informative Sell of $72.05K.
What was Cavalie Fanny's most profitable transaction?
Cavalie Fanny’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Cavalie Fanny's role in Foghorn Therapeutics?
Cavalie Fanny's role in Foghorn Therapeutics is Chief Strategy/Bus Ops Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.